Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis. - Wikidata - wikimedia - TriplyDB

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.

http://www.wikidata.org/entity/Q34308808

about

Symptoms, ultrasound imaging and biochemical markers alone or in combination for the diagnosis of ovarian cancer in women with symptoms suspicious of ovarian cancer Current clinical application of serum biomarkers to detect ovarian cancer Towards an evidence-based approach for diagnosis and management of adnexal masses: findings of the International Ovarian Tumour Analysis (IOTA) studies Thymidine kinase 1 as a diagnostic tumor marker is of moderate value in cancer patients: A meta-analysis.Comparison of serum human epididymis protein 4 and carbohydrate antigen 125 as markers in ovarian cancer: A meta-analysis.Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis.Comparison of HE4, CA125, and ROMA Diagnostic Accuracy: A Prospective and Multicenter Study for Chinese Women With Epithelial Ovarian Cancer.Clinical Use of Cancer Biomarkers in Epithelial Ovarian Cancer: Updated Guidelines From the European Group on Tumor Markers Early detection biomarkers for ovarian cancer.Ovarian cancer: in search of better marker systems based on DNA repair defects Clinical value of serum human epididymis protein 4 assay in the diagnosis of ovarian cancer: a meta-analysis.Evaluation of HE4, CA-125, Risk of Ovarian Malignancy Algorithm (ROMA) and Risk of Malignancy Index (RMI) in the Preoperative Assessment of Patients with Adnexal Mass Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.A Perspective on Ovarian Cancer Biomarkers: Past, Present and Yet-To-Come.The role of human epididymis protein 4 in the diagnosis of epithelial ovarian cancer.Circulating biomarkers in epithelial ovarian cancer diagnosis: from present to future perspective Serum concentrations of HE4 change little during in vitro fertilization.Is serum human epididymis protein 4 ready for prime time?Are serum HE4 or ROMA scores useful to experienced examiners for improving characterization of adnexal masses after transvaginal ultrasonography?HE4, Ca125 and ROMA algorithm for differential diagnosis between benign gynaecological diseases and ovarian cancer.Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer.Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect.Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells Effects of cisplatin on surgically induced endometriosis in a rat model

P2860

Q24187351-A3A1B2DA-354D-48C6-B424-74535C213348 Q26768709-2DC06B95-20B5-4915-A5BC-C1B06798732F Q30414041-689DA4F1-330C-40A8-9411-CEF05959C02B Q31154269-28E31F2D-2098-4578-935F-A38F2BCAF61B Q33733786-E29B7F35-24FE-4694-8FF4-FCF82984E5AB Q34391119-F165EB0B-E4EE-4B4A-AB11-6F5A135EEC3C Q34675023-550ABC41-9B41-4A34-B56E-1C1BD142DCE9 Q36372283-779450F9-FD58-43DB-870A-086D05B1E619 Q36520143-B0A73958-5353-4293-B662-2907B3D63F81 Q36589947-A348670A-DA25-4476-A85B-9F9CBB31B873 Q37053905-887B3F8F-E76C-46C8-B342-48F129A8866F Q37201766-301F5820-9404-40F5-8C00-36C9ED4996D4 Q37359954-5396CE42-E167-49CE-A381-E07F795F5866 Q37729980-610023FA-C893-4C52-B964-C05C50E69328 Q38388103-C952EBC4-3510-4BE5-8479-0389CE853D2C Q38649539-EFE3EF39-EFEB-4338-B111-9CB57D1DC6E4 Q50698085-4E668A60-F7BA-439E-A274-76A7967DC1B0 Q50773867-C6015429-E42A-48A4-8F9F-2457193C2334 Q50857141-F11E23EC-B5D3-4C9D-814E-E7208F6CDA6E Q51091632-56A2BE26-D240-40BF-A6F0-4226A0F90EF5 Q54966156-64D5CA84-8DC4-47C0-BE88-59F0D9AA9CEE Q55280402-13E4C7CA-3B78-44B4-8866-4BD76CFF4D5A Q55430421-02B58E08-3D66-4B7C-91C8-CC7384EB3189 Q58609457-0C634492-E891-47E9-85C5-1E01276FB579 Q58796648-8041F890-F0CD-4DCC-ACD0-24FC2B1913E6

P2860

Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.

http://www.wikidata.org/entity/Q34308808

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@ast

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@en

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@nl

type

label

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@ast

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@en

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@nl

prefLabel

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@ast

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@en

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@nl

P1433

Q34308808-742120CC-858E-4A0A-A3B0-E25DCE837DE6

P1476

Q34308808-90CCC1F3-3ECD-498E-AED4-EE353C6B8A04

P2093

Q34308808-3A257B50-EF28-4580-83CF-F42E981CC80A

Q34308808-48C46F8E-0B54-4FA1-AFC8-D4D1D40D304A

Q34308808-6E4FF625-F222-4341-9D2F-0427D7CDD8FA

Q34308808-6FAE0113-165F-41E4-96DD-E9B4A3BE83A1

Q34308808-8AB4D40C-9B72-4442-9156-E9FC266AC9EC

Q34308808-A7D255EB-F59E-46E2-85C4-308EDE916135

Q34308808-B92EF6A6-4B52-4B06-A5BA-874D020E247B

Q34308808-BFBCD1DC-1835-42B2-800F-EA2A2D68ED6C

P2860

Q34308808-0154EEF2-4054-4E12-9D4A-FDCDF3B5569A

Q34308808-11473445-8572-4CCC-97A2-D131D7F1BBFF

Q34308808-1291352C-624B-4792-A3F4-F7F3ECFEE1EA

Q34308808-1A8398DF-969B-47DC-B884-A19C1A65C408

Q34308808-1B523AD1-1F71-42F8-99FF-57C70DA798D6

Q34308808-1CA5E9A0-C84B-42BB-ADE9-CF020CD3DCA0

Q34308808-252A5A03-A116-45AB-9492-00BC781BDDF6

Q34308808-2729FF81-D73E-402E-BD25-DE2221706692

Q34308808-27994791-DD28-43E1-8BB7-51887EA1B1B6

Q34308808-39727D9B-420E-4F7F-A28B-40275C760F39

P2888

Q34308808-4E226086-0410-40E4-BBBE-CC46FADC7433

P304

Q34308808-90CF8FD3-02A5-4638-9239-AC0CBCF59219

P31

Q34308808-1371BAD2-4AB5-485F-81E8-11BAC7B40F45

Q34308808-63cdb997-165b-4304-bf6d-7ecee489484c

P356

Q34308808-5C2898D6-3AAB-4986-827E-9118FA558655

P407

Q34308808-C0CF7F9D-B87D-495C-B329-B11702480C38

P478

Q34308808-E9E1DBD7-7ED0-4D18-B212-AA03C7BE2929

P577

Q34308808-C6BF79B0-F34A-4D05-B75D-9AC26B3EAD2E

P5875

Q34308808-E1751184-DF80-4AD4-8C6D-3A419E39E21C

P6179

Q34308808-15768D77-AB23-4735-9CFA-B07705253E72

P698

Q34308808-58E194A7-C1BF-48CD-98E6-5990C04F5A33

P921

Q34308808-27B1DF52-9452-4B1F-89A5-055EA6057FB2

Q34308808-AF6D472A-03DF-4083-A07F-D448738E9A68

P932

Q34308808-93AA9AAE-8C56-4960-A974-31F87DA3AB21

P356

1471-2407-12-258

P1433

P1476

Does risk for ovarian malignan ...... arian cancer: a meta-analysis.

@en

P2093

Fake Li

http://www.w3.org/2001/XMLSchema#string

Feng Wang

http://www.w3.org/2001/XMLSchema#string

Kai Chang

http://www.w3.org/2001/XMLSchema#string

Lili Yu

http://www.w3.org/2001/XMLSchema#string

Ming Chen

http://www.w3.org/2001/XMLSchema#string

Ruxiu Tie

http://www.w3.org/2001/XMLSchema#string

Shaoli Deng

http://www.w3.org/2001/XMLSchema#string

Weiping Lu

http://www.w3.org/2001/XMLSchema#string

P2860

No role for quality scores in systematic reviews of diagnostic accuracy studies

Measuring inconsistency in meta-analyses

QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews

Comprehensive analysis of HE4 expression in normal and malignant human tissues.

Empirical evidence of design-related bias in studies of diagnostic tests.

Meta-DiSc: a software for meta-analysis of test accuracy data.

The preclinical natural history of serous ovarian cancer: defining the target for early detection

E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

P2888

1471-2407-12-258

P304

258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-12-258

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227393379

http://www.w3.org/2001/XMLSchema#string

P6179

1001981020

http://www.w3.org/2001/XMLSchema#string

P698

22712526

http://www.w3.org/2001/XMLSchema#string

P921

P932

3443004

http://www.w3.org/2001/XMLSchema#string